Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01624220 · ClinicalTrials.gov registry record · NA
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT01624220: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT01624220 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01624220, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The goal of the first part of this clinical research study is to learn how to deliver more accurate radiation treatment of tumors in the spine. Researchers also want to learn how internal organs might move during radiation treatment. The goal of the second part of this study is to learn if it is safe to allow slightly more radiation to the normal esophagus when spinal tumors close by are being treated. This may result in better tumor control.
Interventions
- BEHAVIORAL Questionnaires
- RADIATION Spinal SBRT (Standard Dose)
- RADIATION Spinal SBRT (Higher Dose)
- PROCEDURE Gold Seed Implantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2012-08-03 |
| Est. Completion | 2023-04-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01624220
The ClinicalTrials.gov registry entry for NCT01624220 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Questionnaires is the first listed.
NCT01624220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01624220 about?
NCT01624220 is a clinical study titled "A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy". The goal of the first part of this clinical research study is to learn how to deliver more accurate radiation treatment of tumors in the spine. Researchers also want to learn how internal organs might move during radiation treatment. The goal of the second part of this study is to learn if it is sa...
What is the current status of trial NCT01624220?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2012-08-03. Estimated completion is 2023-04-14.
What interventions are being tested in trial NCT01624220?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Spinal SBRT (Standard Dose) (RADIATION), Spinal SBRT (Higher Dose) (RADIATION), Gold Seed Implantation (PROCEDURE).
Who is sponsoring clinical trial NCT01624220?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.